Cited by 40Iron Metabolism and DisordersTrace Elements in HealthFerroptosis and cancer prognosis

Joint Model of Iron and Hepcidin During the Menstrual Cycle in Healthy Women

Open access
Angeli, Adeline, Lainé, Fabrice, Lavenu, Audrey, Ropert, Martine, Lacut, Karine, Gissot, Valérie, Sacher-Huvelin, Sylvie, Jezequel, Caroline +3 more·2016·The AAPS Journal

Abstract

Hepcidin regulates serum iron levels, and its dosage is used in differential diagnostic of iron-related pathologies. We used the data collected in the HEPMEN (named after HEPcidin during MENses) study to investigate the joint dynamics of serum hepcidin and iron during the menstrual cycle in healthy women. Ninety menstruating women were recruited after a screening visit. Six fasting blood samples for determination of iron-status variables were taken in the morning throughout the cycle, starting on the second day of the period. Non-linear mixed effect models were used to describe the evolution of iron and hepcidin. Demographic and medical covariates were tested for their effect on model parameters. Parameter estimation was performed using the SAEM algorithm implemented in the Monolix software. A general pattern was observed for both hepcidin and iron, consisting of an initial decrease during menstruation, followed by a rebound and stabilising during the second half of the cycle. We developed a joint model including a menstruation-induced decrease of both molecules at the beginning of the menses and a rebound effect after menses. Iron stimulated the release of hepcidin. Several covariates, including contraception, amount of blood loss and ferritin, were found to influence the parameters. The joint model of iron and hepcidin was able to describe the fluctuations induced by blood loss from menstruation in healthy non-menopausal women and the subsequent regulation. The HEPMEN study showed fluctuations of iron-status variables during the menstrual cycle, which should be considered when using hepcidin measurements for diagnostic purposes in women of child-bearing potential.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1208/s12248-016-9875-4

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In the late follicular phase (days 6-14), the gradual rise in estrogen maintains low hepcidin activity, enabling iron absorption and recycling in the days following menses.

    “In the late follicular phase (days 6–14), the gradual rise in estrogen maintains low hepcidin activity, enabling iron absorption and recycling in the days following menses [320].”

    From International society of sports nutrition position stand: nutritional concerns of the female athlete (2023) · cites this paper as [320]

    The Evolution of Iron-Status Variable During the Study section reports that hepcidin decreased during menses but rebounded after menses, reaching above-baseline concentrations; the Sampling Design section places that rebound between days 6 and 12. This is contrary to the claim that hepcidin remains low on days 6–14. The cited passages do not establish estrogen as the cause. (LLM, conf=0.87)

    Checked by a reasoning model — may be wrong.

    Experimental — accuracy not yet measured
  • Previous research results demonstrate a rebound in hepcidin, serum iron, and transferrin saturation post-ovulation that stabilizes during the luteal phase.

    “Previous research results demonstrate a rebound in hepcidin, serum iron, and transferrin saturation post-ovulation that stabilizes during the luteal phase [320].”

    From International society of sports nutrition position stand: nutritional concerns of the female athlete (2023) · cites this paper as [320]

    The section “Evolution of Iron-Status Variable During the Study” reports a rebound in iron and hepcidin after menses, a similar pattern in transferrin saturation, and stabilization during the second half of the cycle. It does not place the rebound post-ovulation; the Discussion describes it as occurring mid-cycle. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Wakelkamp M, Alván G, Gabrielsson J, Paintaud G. Pharmaco- dynamic modeling of furosemide tolerance after multiple intra- venous administration. Clin Pharmacol Ther. 1996;60:75-88.
  2. Sharma A, Ebling WF, Jusko WJ. Precursor-dependent indirect pharmacodynamic response model for tolerance and rebound phenomena. J Pharm Sci. 1998;87:1577-84.

Cited by

Sorted by citations

Authors
Angeli, A., Lainé, F., Lavenu, A., Ropert, M., Lacut, K., Gissot, V., Sacher-Huvelin, S., Jezequel, C., Moignet, A., Laviolle, B., & Comets, E.
Affiliations
Inserm (FR)
Corresponding author
Comets, Emmanuelle
Venue
The AAPS Journal
Published
2016-02-02
Volume
18
Issue
2
Pages
490-504
ISSN
1550-7416 (ISSN-L)
OpenAlex
W2274448441
Cited by
40
References
43
Citations by year
2026: 4 · 2025: 4 · 2024: 3 · 2023: 15 · 2022: 6 · 2021: 2 · 2020: 2 · 2019: 1 · 2017: 3
FWCI
1.27
Type
journal article
Language
en
Open access
Locations
  • The AAPS Journal (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
  • Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Ferroptosis and cancer prognosis
Keywords
hepcidin, serum iron, menstrual cycle, iron status, menstruation, blood loss, ferritin, contraception, joint modeling, women of reproductive age, iron regulation
MeSH terms
Adult, Anti-Infective Agents, Female, Humans, Iron, Menstrual Cycle, Models, Biological, Young Adult, Healthy Volunteers, Hepcidins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review